Distillate Capital Partners LLC reduced its stake in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 6.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 170,575 shares of the technology company's stock after selling 11,109 shares during the period. Distillate Capital Partners LLC owned 0.15% of Amdocs worth $14,523,000 at the end of the most recent quarter.
Several other large investors also recently made changes to their positions in the stock. Axxcess Wealth Management LLC boosted its holdings in Amdocs by 5.4% during the fourth quarter. Axxcess Wealth Management LLC now owns 2,431 shares of the technology company's stock valued at $207,000 after acquiring an additional 124 shares during the period. Principal Securities Inc. grew its position in Amdocs by 10.4% in the fourth quarter. Principal Securities Inc. now owns 1,341 shares of the technology company's stock valued at $114,000 after acquiring an additional 126 shares during the period. Global Retirement Partners LLC lifted its holdings in Amdocs by 45.6% during the 4th quarter. Global Retirement Partners LLC now owns 559 shares of the technology company's stock valued at $48,000 after purchasing an additional 175 shares during the last quarter. CIBC Asset Management Inc raised its position in Amdocs by 5.2% in the 4th quarter. CIBC Asset Management Inc now owns 3,621 shares of the technology company's stock valued at $308,000 after purchasing an additional 180 shares during the last quarter. Finally, KFG Wealth Management LLC increased its stake in shares of Amdocs by 8.2% in the fourth quarter. KFG Wealth Management LLC now owns 2,496 shares of the technology company's stock valued at $213,000 after buying an additional 189 shares in the last quarter. Institutional investors own 92.02% of the company's stock.
Amdocs Trading Down 0.1 %
DOX stock traded down $0.10 during midday trading on Thursday, reaching $83.18. The company's stock had a trading volume of 808,930 shares, compared to its average volume of 701,855. The business's 50-day simple moving average is $87.51 and its 200-day simple moving average is $87.19. The stock has a market cap of $9.39 billion, a PE ratio of 19.30, a price-to-earnings-growth ratio of 1.47 and a beta of 0.59. Amdocs Limited has a 52 week low of $74.41 and a 52 week high of $93.34. The company has a quick ratio of 1.20, a current ratio of 1.16 and a debt-to-equity ratio of 0.22.
Amdocs (NASDAQ:DOX - Get Free Report) last announced its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share for the quarter, missing analysts' consensus estimates of $1.64 by ($0.19). Amdocs had a net margin of 10.19% and a return on equity of 18.89%. As a group, sell-side analysts expect that Amdocs Limited will post 6.21 EPS for the current year.
Amdocs Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Monday, March 31st will be given a $0.527 dividend. The ex-dividend date of this dividend is Monday, March 31st. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.53%. This is a boost from Amdocs's previous quarterly dividend of $0.48. Amdocs's dividend payout ratio is currently 48.72%.
Analysts Set New Price Targets
Separately, StockNews.com lowered shares of Amdocs from a "strong-buy" rating to a "buy" rating in a research report on Friday, February 28th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $101.20.
Check Out Our Latest Research Report on Amdocs
Amdocs Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Recommended Stories

Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.